Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 23, 2015 Filed Apr 24, 2015 18:00 UTC |
FERGUSSON FRANCES DDirector
|
GrantPhantom Stock Units · Derivative | 4,595.588 | $35.36 | $162,499.99 |
DisclosureSEC source: 0001225208-15-010349 · doc4.xml · derivative · entry 1 FERGUSSON FRANCES D · CIK 0001249038 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,294.797 Underlying: Common Stock · 4,595.588 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 23, 2015 Filed Apr 24, 2015 18:00 UTC |
HOBBS HELENDirector
|
GrantPhantom Stock Units · Derivative | 4,595.588 | $35.36 | $162,499.99 |
DisclosureSEC source: 0001225208-15-010350 · doc4.xml · derivative · entry 1 HOBBS HELEN · CIK 0001537057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,395.19 Underlying: Common Stock · 4,595.588 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 23, 2015 Filed Apr 24, 2015 18:00 UTC |
KILTS JAMES MDirector
|
GrantPhantom Stock Units · Derivative | 4,595.588 | $35.36 | $162,499.99 |
DisclosureSEC source: 0001225208-15-010351 · doc4.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,271.38 Underlying: Common Stock · 4,595.588 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 23, 2015 Filed Apr 24, 2015 18:00 UTC |
NORA JOHNSON SUZANNE MDirector
|
GrantPhantom Stock Units · Derivative | 4,595.588 | $35.36 | $162,499.99 |
DisclosureSEC source: 0001225208-15-010353 · doc4.xml · derivative · entry 1 NORA JOHNSON SUZANNE M · CIK 0001310264 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,393.682 Underlying: Common Stock · 4,595.588 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 23, 2015 Filed Apr 24, 2015 18:00 UTC |
SANGER STEPHEN WDirector
|
GrantPhantom Stock Units · Derivative | 4,595.588 | $35.36 | $162,499.99 |
DisclosureSEC source: 0001225208-15-010354 · doc4.xml · derivative · entry 1 SANGER STEPHEN W · CIK 0001204994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,990.493 Underlying: Common Stock · 4,595.588 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 23, 2015 Filed Apr 24, 2015 18:00 UTC |
SMITH JAMES CDirector
|
GrantPhantom Stock Units · Derivative | 4,595.588 | $35.36 | $162,499.99 |
DisclosureSEC source: 0001225208-15-010355 · doc4.xml · derivative · entry 1 SMITH JAMES C · CIK 0001611777 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,543.4482 Underlying: Common Stock · 4,595.588 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 23, 2015 Filed Apr 24, 2015 18:00 UTC |
Tessier-Lavigne MarcDirector
|
GrantPhantom Stock Units · Derivative | 4,595.588 | $35.36 | $162,499.99 |
DisclosureSEC source: 0001225208-15-010356 · doc4.xml · derivative · entry 1 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,099.964 Underlying: Common Stock · 4,595.588 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 15, 2015 Filed Apr 16, 2015 21:31 UTC |
BOURLA ALBERTGroup President
|
GrantPhantom Stock Units SSP · Derivative | 16 | $35.21 | $563.36 |
DisclosureSEC source: 0001225208-15-010079 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,692 Underlying: Common Stock · 16 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 15, 2015 Filed Apr 16, 2015 21:31 UTC |
JOHNSON RADY AExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 3 | $35.21 | $105.63 |
DisclosureSEC source: 0001225208-15-010080 · doc4.xml · derivative · entry 1 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,314 Underlying: Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 15, 2015 Filed Apr 16, 2015 21:31 UTC |
MADDALUNA ANTHONY JExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 171 | $35.21 | $6,020.91 |
DisclosureSEC source: 0001225208-15-010081 · doc4.xml · derivative · entry 1 MADDALUNA ANTHONY J · CIK 0001566333 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,412 Underlying: Common Stock · 171 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 15, 2015 Filed Apr 16, 2015 21:31 UTC |
READ IAN CDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 126 | $35.21 | $4,436.46 |
DisclosureSEC source: 0001225208-15-010082 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,146 Underlying: Common Stock · 126 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 09, 2015 Filed Apr 14, 2015 01:00 UTC |
BOURLA ALBERTGroup President
|
GrantPhantom Stock Units SSP · Derivative | 92 | $35.03 | $3,222.76 |
DisclosureSEC source: 0001225208-15-009989 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,676 Underlying: Common Stock · 92 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 09, 2015 Filed Apr 14, 2015 01:00 UTC |
JOHNSON RADY AExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 33 | $35.03 | $1,155.99 |
DisclosureSEC source: 0001225208-15-009990 · doc4.xml · derivative · entry 1 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,311 Underlying: Common Stock · 33 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 09, 2015 Filed Apr 14, 2015 01:01 UTC |
MADDALUNA ANTHONY JExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 541 | $35.03 | $18,951.23 |
DisclosureSEC source: 0001225208-15-009991 · doc4.xml · derivative · entry 1 MADDALUNA ANTHONY J · CIK 0001566333 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,241 Underlying: Common Stock · 541 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 09, 2015 Filed Apr 14, 2015 01:02 UTC |
READ IAN CDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 4,100 | $35.03 | $143,623.00 |
DisclosureSEC source: 0001225208-15-009992 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,020 Underlying: Common Stock · 4,100 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 31, 2015 Filed Apr 1, 2015 22:21 UTC |
BOURLA ALBERTGroup President
|
GrantPhantom Stock Units SSP · Derivative | 15 | $34.79 | $521.85 |
DisclosureSEC source: 0001225208-15-009038 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,584 Underlying: Common Stock · 15 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 31, 2015 Filed Apr 1, 2015 22:21 UTC |
JOHNSON RADY AExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 4 | $34.79 | $139.16 |
DisclosureSEC source: 0001225208-15-009039 · doc4.xml · derivative · entry 1 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,278 Underlying: Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 31, 2015 Filed Apr 1, 2015 22:21 UTC |
MADDALUNA ANTHONY JExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 159 | $34.79 | $5,531.61 |
DisclosureSEC source: 0001225208-15-009040 · doc4.xml · derivative · entry 1 MADDALUNA ANTHONY J · CIK 0001566333 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,701 Underlying: Common Stock · 159 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 31, 2015 Filed Apr 1, 2015 22:21 UTC |
READ IAN CDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 131 | $34.79 | $4,557.49 |
DisclosureSEC source: 0001225208-15-009041 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,926 Underlying: Common Stock · 131 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 27, 2015 Filed Mar 31, 2015 23:31 UTC |
SMITH JAMES CDirector
|
GrantPhantom Stock Units · Derivative | 959.311 | $34.53 | $33,125.01 |
DisclosureSEC source: 0001225208-15-008874 · doc4.xml · derivative · entry 1 SMITH JAMES C · CIK 0001611777 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,947.8602 Underlying: Common Stock · 959.311 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| March 27, 2015 Filed Mar 31, 2015 23:32 UTC |
SANGER STEPHEN WDirector
|
GrantPhantom Stock Units · Derivative | 1,176.513 | $34.53 | $40,624.99 |
DisclosureSEC source: 0001225208-15-008875 · doc4.xml · derivative · entry 1 SANGER STEPHEN W · CIK 0001204994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,394.905 Underlying: Common Stock · 1,176.513 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| March 27, 2015 Filed Mar 31, 2015 23:32 UTC |
NARAYEN SHANTANUDirector
|
GrantPhantom Stock Units · Derivative | 995.511 | $34.53 | $34,374.99 |
DisclosureSEC source: 0001225208-15-008876 · doc4.xml · derivative · entry 1 NARAYEN SHANTANU · CIK 0001224154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,246.146 Underlying: Common Stock · 995.511 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| March 27, 2015 Filed Mar 31, 2015 23:32 UTC |
KILTS JAMES MDirector
|
GrantPhantom Stock Units · Derivative | 1,176.513 | $34.53 | $40,624.99 |
DisclosureSEC source: 0001225208-15-008877 · doc4.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,675.792 Underlying: Common Stock · 1,176.513 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| March 13, 2015 Filed Mar 17, 2015 16:41 UTC |
MADDALUNA ANTHONY JExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 2,314 | $34.00 | $78,676.00 |
DisclosureSEC source: 0001225208-15-007998 · doc4.xml · derivative · entry 2 MADDALUNA ANTHONY J · CIK 0001566333 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,555 Underlying: Common Stock · 2,314 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 13, 2015 Filed Mar 17, 2015 16:41 UTC |
MADDALUNA ANTHONY JExecutive Vice President
|
GrantPhantom Stock Units (AIP) · Derivative | 8,565 | $34.00 | $291,210.00 |
DisclosureSEC source: 0001225208-15-007998 · doc4.xml · derivative · entry 1 MADDALUNA ANTHONY J · CIK 0001566333 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,102 Underlying: Common Stock · 8,565 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent incentive compensation that has been deferred and will be settled in ten annual installments. F2 · derivative.expiration_date: These units represent incentive compensation that has been deferred and will be settled in ten annual installments. Read SEC document |
| March 13, 2015 Filed Mar 17, 2015 16:41 UTC |
BOURLA ALBERTGroup President
|
GrantPhantom Stock Units SSP · Derivative | 300 | $34.00 | $10,200.00 |
DisclosureSEC source: 0001225208-15-007999 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,569 Underlying: Common Stock · 300 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 13, 2015 Filed Mar 17, 2015 16:41 UTC |
READ IAN CDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 5,423 | $34.00 | $184,382.00 |
DisclosureSEC source: 0001225208-15-008001 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,832 Underlying: Common Stock · 5,423 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 13, 2015 Filed Mar 17, 2015 16:41 UTC |
JOHNSON RADY AExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 41 | $34.00 | $1,394.00 |
DisclosureSEC source: 0001225208-15-008000 · doc4.xml · derivative · entry 1 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,274 Underlying: Common Stock · 41 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 12, 2015 Filed Mar 13, 2015 14:39 UTC |
SUSMAN SALLYExecutive Vice President
|
SaleCommon Stock | 46,179 | $34.00 | $1,570,086.00 |
DisclosureSEC source: 0001225208-15-007778 · doc4.xml · nonDerivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,899 Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 25,332 | $34.58 | $875,980.56 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 24 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,408,457 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 18,021 | $34.57 | $622,985.97 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 23 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,433,789 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 4,827 | $34.59 | $166,965.93 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 22 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,451,810 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 3,600 | $34.75 | $125,100.00 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 21 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,456,637 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 3,000 | $34.74 | $104,220.00 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 20 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,460,237 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 1,800 | $34.73 | $62,514.00 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 19 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,463,237 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 1,600 | $34.76 | $55,616.00 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 18 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,465,037 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 1,400 | $34.77 | $48,678.00 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 17 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,466,637 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 900 | $34.72 | $31,248.00 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 16 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,468,037 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 800 | $34.69 | $27,752.00 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 15 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,468,937 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 700 | $34.60 | $24,220.00 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 14 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,469,737 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 700 | $34.70 | $24,290.00 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 13 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,470,437 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 700 | $34.71 | $24,297.00 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 12 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,471,137 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 700 | $34.79 | $24,353.00 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 11 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,471,837 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 600 | $34.64 | $20,784.00 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 10 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,472,537 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 500 | $34.67 | $17,335.00 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 9 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,473,137 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 500 | $34.78 | $17,390.00 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 8 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,473,637 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 420 | $34.61 | $14,536.20 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 7 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,474,137 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 400 | $34.68 | $13,872.00 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 6 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,474,557 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 300 | $34.62 | $10,386.00 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 5 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,474,957 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
| March 05, 2015 Filed Mar 7, 2015 00:19 UTC |
READ IAN CDirector · Chairman & CEO
|
SaleCommon Stock | 200 | $34.63 | $6,926.00 |
DisclosureSEC source: 0001225208-15-007187 · doc4.xml · nonDerivative · entry 4 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,475,257 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 4, 2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.